senna alexandrina

Botanicalexperimental

Senna alexandrina is an ornamental plant in the genus Senna. It is used in herbalism. It grows natively in upper Egypt, especially in the Nubian region, and near Khartoum (Sudan), where it is cultivated commercially. It is also grown elsewhere, notably in India and Somalia. — Wikipedia

Clinical trial activity

6 trials · 7 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
1

Earliest trial started Jun 1, 2010 (NCT00990951)

Timeline

2010s

  1. Jan 1, 2010

    Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 2018

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • senna alexandrina
  • sennaglucosides
  • senna glycoside

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06825260Phase 4Mar 31, 2025St. Joseph's Health, New York
NCT03593252N/ASep 1, 2018McMaster University
NCT03501498N/AApr 30, 2018University Hospital Plymouth NHS Trust
NCT03342157Phase 2Apr 2, 2018University of Wisconsin
NCT03745183N/ANov 30, 2014Philippine Dermatological Society
NCT00990951Phase 3Jun 1, 2010Federal University of Ceara, Marjan Industria e Comercio ltda
Showing 6 of 6 trials
Page 1 / 1

Organizations

Research & Development (7)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Federal University of CearaAcademic/Hospital1012010
Marjan Industria e Comercio ltdaFor profit1112010
McMaster UniversityAcademic/Hospital1112018
Philippine Dermatological SocietyAcademic/Hospital1112014
St. Joseph's Health, New YorkAcademic/Hospital1112025
University Hospital Plymouth NHS TrustAcademic/Hospital1112018
University of WisconsinAcademic/Hospital1112018
7 organizations
Page 1 / 1